Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: RNA-based therapy in the management of lipid disorders: a review

Fig. 1

Development of RNA-based therapies for the treatment of cardiovascular and other disorders. AsO: antisense oligonucleotides; FDA: Food and Drug Administration; EMA: European Medicines Agency; CV: cardiovascular; HoFH: homozygous familial hypercholesterolemia; siRNA: small interfering ribonucleic acids; hATTR: hereditary transthyretin amyloidosis; Lp(a): lipoprotein(a)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X